Filters: author is Tukker [Clear All Filters]
- 2003
Mechanism-based pharmacokinetic/pharmacodynamic modeling of the electroencephalogram effects of GABAA receptor modulators: in vitro-in vivo correlations,
J Pharmacol Exp Ther, vol. 304, no. 1, pp. 88-101. DOI
- 2000
- 1998
Metabolic and cardiovascular effects of the adenosine A1 receptor agonist N6-(p-sulfophenyl)adenosine in diabetic Zucker rats: influence of the disease on the selectivity of action,
J Pharmacol Exp Ther, vol. 287, no. 1, pp. 21-30.
Influence of different fat emulsion-based intravenous formulations on the pharmacokinetics and pharmacodynamics of propofol,
Pharm Res, vol. 15, no. 3, pp. 442-8.
Selectivity of action of 8-alkylamino analogues of N6-cyclopentyladenosine in vivo: haemodynamic versus anti-lipolytic responses in rats,
Br J Pharmacol, vol. 124, no. 3, pp. 607-18. DOI
- 1997
Pharmacokinetic-pharmacodynamic modelling of the EEG effect of alfentanil in rats,
J Pharmacol Toxicol Methods, vol. 38, no. 2, pp. 99-108. DOI
- 1992
In vivo characterization of the pharmacodynamic interaction of a benzodiazepine agonist and antagonist: midazolam and flumazenil,
J Pharmacol Exp Ther, vol. 260, no. 1, pp. 36-44.
Modeling of the effect site equilibration kinetics and pharmacodynamics of racemic baclofen and its enantiomers using quantitative EEG effect measures,
J Pharmacol Exp Ther, vol. 261, no. 1, pp. 88-95.
- 1991
Pharmacokinetic-pharmacodynamic modelling of the EEG effects of midazolam in individual rats: influence of rate and route of administration,
Br J Pharmacol, vol. 102, no. 3, pp. 663-8.


